METHODS OF IDENTIFYING AGENTS THAT INHIBIT THE GROWTH OF CANCER CELLS

The present invention is directed to methods of identifying agents useful for inhibiting cancer cells. The agents bind to one of the proteins described herein, or to a gene or mRNA encoding such protein. The invention is also directed to methods for inhibiting cancer cells by administering an agent...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	RHOADES, KRISTINA, TAN, PHILIP, GRIFMAN, MIRTA, DEFIFE, KRISTIN, LI, HENRY, ROGERS, CHERYL, WONG-STAAL, FLOSSIE, HU, XIUYUAN, KE, NING, FAN, WUFANG, HABITA, CELLIA, TRITZ, RICHARD
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR COMPOSITIONS THEREOF CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES OF PREPARING SUCH COMPOSITIONS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention is directed to methods of identifying agents useful for inhibiting cancer cells. The agents bind to one of the proteins described herein, or to a gene or mRNA encoding such protein. The invention is also directed to methods for inhibiting cancer cells by administering an agent that binds to one of the proteins described herein, or to a gene or mRNA encoding such protein. L'invention concerne des méthodes permettant d'identifier des agents utiles pour l'inhibition des cellules cancéreuses. Ces agents se lient soit à l'une des protéines décrites dans l'invention, soit à un gène ou à un ARNm codant pour cette protéine. L'invention concerne également des méthodes permettant d'inhiber les cellules cancéreuses en administrant un agent qui se lie à l'une des protéines décrites dans l'invention, soit à un gène, soit à un ARNm codant pour cette protéine.